Fed. Circ. Sticks With Ruling In Bard's $68M Patent Fight

By Andrew Karpan (January 15, 2021, 9:59 PM EST) -- The full Federal Circuit refused on Friday to take another look at a panel ruling that revived C.R. Bard's $67.5 million infringement claims and undid a Delaware federal judge's finding that the medical device maker's patents were invalid.

The Federal Circuit denied without comment both a petition from AngioDynamics for a panel rehearing and a petition for an en banc rehearing, leaving intact the panel's November ruling that said Bard Peripheral Vascular Inc. deserves to finish the jury trial that U.S. District Judge Joseph F. Bataillon shut down in 2019 when he ruled that Bard's power port patents were abstract and...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!